date	content
Aug. 2017	Listing in the Canada Stock Exchange (CSE)
Oct. 2016	Started production of hair growth product containing 5 kinds of growth factors
Oct. 2016	Bio-similar and a FMD Vaccine joint factory project with ORNA, Turkey
Oct. 2016	Contracted joint venture for FMD Vaccine production with Pharos Vaccine, Korea
Aug. 2016	Established Biopharma-Switzerland in Zurich, Switzerland (main shareholder)
Jul. 2016	Final discussing a Bio-similar joint factory project with Royan Group, Iran
Sep. 2015	Completed capital increase with consideration (issued total 3,158,887 shares)
Jan. 2015	Agreed with Biocurepharm-Atabay(Turkey) for joint development of Ranibizumab
Aug. 2012	Attracted FDI USD500Mil from Macauley Gehler, Singapore
Jan. 2012	Established Biocurepharm-MG in Singapore with Macauley Gehler
Mar. 2011	Completed joint development of a detection kit of breast cancer (clinical test started)
Dec. 2007	Achieved export of USD 4.5 million
Nov. 2006	Awarded the national export tower of USD 1 million
Aug. 2005	Company founded (Paid-in capital of USD 50,000)